UA51253A - Solid dosage form of melanin-containing medicinal preparation and its formulation - Google Patents

Solid dosage form of melanin-containing medicinal preparation and its formulation

Info

Publication number
UA51253A
UA51253A UA2002021030A UA200221030A UA51253A UA 51253 A UA51253 A UA 51253A UA 2002021030 A UA2002021030 A UA 2002021030A UA 200221030 A UA200221030 A UA 200221030A UA 51253 A UA51253 A UA 51253A
Authority
UA
Ukraine
Prior art keywords
melanin
mixture
starch
dosage form
granulated
Prior art date
Application number
UA2002021030A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Григорій Вікторович Костюк
Григорий Викторович Костюк
Валентина Миколаївна КОВАЛЕНКО
Валентина Николаевна Коваленко
Ольга Миколаївна Олексійчук
Філя Іванівна Жебровська
Филя Ивановна Жебровская
Марина Іллінічна Борщевська
Марина Ильинична Борщевская
Original Assignee
Відкрите Акціонерне Товариство "Фармак"
Открытое Акционерное Общество "Фармак"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Відкрите Акціонерне Товариство "Фармак", Открытое Акционерное Общество "Фармак" filed Critical Відкрите Акціонерне Товариство "Фармак"
Priority to UA2002021030A priority Critical patent/UA51253A/en
Publication of UA51253A publication Critical patent/UA51253A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The solid dosage form of the melanin-containing medicinal preparation is disclosed. The melanin is isolated from the biomass of Cladosporium Cladosporioides 396. Besides melanin the following ingredients are included: the lactose, the potato starch, aerosil, calcium stearate monohydrate. The dosage form is prepared in several steps. The active substance is mixed with the potato starch. The mixture is soaked, granulated and dried. The dry granules are treated with the mixture of calcium stearate monohydrate and the starch. The treated granules are then pressed into the tablets. Melanin isolated from the biomass of Cladosporium Cladosporioides 396 represents the active substance. The sticky mass of the starch is prepared in advance. The soaking is performed simultaneously with mixing. Then the wet mixture is granulated. The wet granulate is dried and subjected to further granulation. The dry granules are treated with the mixture of aerosil and lactose. The mixture is soaked in the sticky aqueous mass of the starch, granulated and dried at 50-60°С.
UA2002021030A 2002-02-08 2002-02-08 Solid dosage form of melanin-containing medicinal preparation and its formulation UA51253A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA2002021030A UA51253A (en) 2002-02-08 2002-02-08 Solid dosage form of melanin-containing medicinal preparation and its formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA2002021030A UA51253A (en) 2002-02-08 2002-02-08 Solid dosage form of melanin-containing medicinal preparation and its formulation

Publications (1)

Publication Number Publication Date
UA51253A true UA51253A (en) 2002-11-15

Family

ID=74246026

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2002021030A UA51253A (en) 2002-02-08 2002-02-08 Solid dosage form of melanin-containing medicinal preparation and its formulation

Country Status (1)

Country Link
UA (1) UA51253A (en)

Similar Documents

Publication Publication Date Title
CO5070636A1 (en) PROCESS FOR THE PREPARATION OF SOLID GALENIC FORMS WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS FOR PERORAL USE
JP2010053143A (en) Pharmaceutical composition quickly disintegrating in oral cavity and method for producing the same
RU2019110089A (en) ADVANCED MACHINE AND METHOD OF STRETCH FILM PACKAGING OF PRODUCTS SUPPLIED IN BLOCKS OR SEPARATE
WO2007107787A3 (en) Liquid and solid dosage formulations containing date fruit (phoenix dactylifera)
Saravanan et al. Hydroxypropyl methylcellulose based cephalexin extended release tablets: Influence of tablet formulation, hardness and storage on in vitro release kinetics
UA51253A (en) Solid dosage form of melanin-containing medicinal preparation and its formulation
UA27954C2 (en) Biologically active substance of a pharmaceutical composition for treatment of hyperglycemias and pharmaceutical composition having antihyperglicemical activity
RU2003122027A (en) PHARMACEUTICAL COMPOSITION Possessing Nootropic Activity, and Method for its Preparation
RU2012124704A (en) MEDICINES BASED ON DRY EXTRACTS OF MEDICINAL PLANTS AND METHOD FOR PRODUCING IT (OPTIONS)
DE60220551D1 (en) TABLETS WITH DELAYED ACTIVE INGREDIENT CONTAINING INDAPAMID
US20070212399A1 (en) Pyroligneous liquor sheet
Bansal et al. Effect of formulation and process variables on the dissolution profile of naproxen sodium from tablets
RU2287338C2 (en) Method for obtaining tablets out of dry st. john's wort extract
US6322812B1 (en) Pharmaceutical forms for the oral administration of mesna
EA200901191A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING ACTIVE INGREDIENT ATORVASTATIN
RU2190392C1 (en) Doxazozine-based pharmaceutical composition
UA40999A (en) Method for manufacturing solid form of pharmaceutical composition
RU2019110098A (en) SOLID PREPARATION OF ABIRATERONE ACETATE OBTAINED USING THE METHOD OF LIQUID GRANULATION
RU99107824A (en) TABLET COMPOSITION AND METHOD FOR PREPARING TABLETS
DK1729735T3 (en) Process for the preparation of compressed solid dosage forms suitable for use with low water solubility drugs and compressed solid dosage forms prepared thereby
RU96111064A (en) COMPOSITION FOR ANTIALLERGICAL, ANTIASTICATIC MEDICINE AND METHOD FOR OBTAINING TABLETS
RU2001110333A (en) METHOD FOR PRODUCING SOLID PHARMACEUTICAL COMPOSITION
RU2286779C2 (en) Pelleted pharmaceutical composition with diuretic and antihypertension properties and method for production thereof
UA28103C2 (en) Method of orthophen tabletted form obtaining
RU2254860C2 (en) Pharmaceutical composition eliciting antiviral activity as solid dosed formulation and method for its preparing